217 related articles for article (PubMed ID: 11741164)
1. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
2. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.
Stevens SJ; Blank BS; Smits PH; Meenhorst PL; Middeldorp JM
AIDS; 2002 May; 16(7):993-1001. PubMed ID: 11953465
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
5. Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.
Giron LB; Ramos da Silva S; Barbosa AN; Monteiro de Barros Almeida RA; Rosário de Souza Ld; Elgui de Oliveira D
J Med Virol; 2013 Dec; 85(12):2110-8. PubMed ID: 24014234
[TBL] [Abstract][Full Text] [Related]
6. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Ling PD; Vilchez RA; Keitel WA; Poston DG; Peng RS; White ZS; Visnegarwala F; Lewis DE; Butel JS
Clin Infect Dis; 2003 Nov; 37(9):1244-9. PubMed ID: 14557970
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
10. Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients.
Panagiotakis SH; Soufla G; Baritaki S; Sourvinos G; Passam A; Zagoreos I; Stavrianeas N; Spandidos DA
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):10-8. PubMed ID: 17263627
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study.
Yan Y; Ren Y; Chen R; Hu J; Ji Y; Yang J; Shen J; Hu L; Pei H; Wang J; Qiu Y; Lu H; Huang L
Virol Sin; 2018 Jun; 33(3):227-233. PubMed ID: 29654554
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
[TBL] [Abstract][Full Text] [Related]
14. Close relationship between immunoglobulin secreting-cells and Epstein-Barr virus reservoir in patients infected with HIV.
Ouedraogo DE; Tuaillon E; Rubbo PA; Bollore K; Foulongne V; Reynes J; Vendrell JP
J Med Virol; 2014 Jan; 86(1):30-7. PubMed ID: 24114930
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
[TBL] [Abstract][Full Text] [Related]
16. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.
Legoff J; Amiel C; Calisonni O; Fromentin D; Rajoely B; Abuaf N; Tartour E; Rozenbaum W; Bélec L; Nicolas JC
J Clin Immunol; 2004 Mar; 24(2):125-34. PubMed ID: 15024179
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
18. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
[TBL] [Abstract][Full Text] [Related]
19. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
